An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes

M. Reni, H. Riess, E. O'Reilly, A. Santoro, J. Park, T. Bekaii-Saab, M. Tempero, Y. Shan, T. Macarulla, E. Van Cutsem, M. Noel, J. Berlin, A. Biankin, N. Dhani, G. Frassineti, D. Goldstein, A. Romano, Y. Le Bruchec, P. Philip

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)iv126
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Jul 1 2019

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this